Taysha Gene Therapies, Inc. (TSHA)

Taysha Gene Therapies Revenue

Taysha Gene Therapies had revenue of $1.79M in the quarter ending September 30, 2024, a decrease of -62.33%. This brings the company's revenue in the last twelve months to $9.92M, down -30.90% year-over-year. In the year 2023, Taysha Gene Therapies had annual revenue of $15.45M with 517.55% growth.

• Revenue (ttm): $9.92M
• Revenue Growth: -30.90%
• P/S Ratio: 43.98
• Revenue / Employee: $190,673
• Employees: 52
• Market Cap: 379.15M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	15.45M	12.95M	517.55%
Dec 31, 2022	2.50M	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	-	-	-
Dec 31, 2019	-	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.